Collaboration between pharma and medtech industries is the key to future innovative healthcare solutions, with an increasing reliance on combined products developed through both industries.
The MPP Association draws together companies from the pharmaceutical and medtech sector and provides opportunities to exchange knowledge and collaborate in technology and regulatory areas related to combined products.
The MPP’s objectives are:
To enhance synergies between the pharma and medtech industry
To establish new collaboration models to ensure and accelerate market access for safe and innovative treatment options
To support government and regulators in developing a balanced and proportionate regulatory and political framework for combined products